AbundRX review
A start, not a rate
AbundRX prices its programs from $99 and $149 without ever saying what period either figure buys.
Our verdict
Every pricing line on AbundRX opens with the words starting at, and none of them closes with a period of time. The homepage, the product cards and the FAQ all give $99 for semaglutide and $149 for tirzepatide, and not one attaches a month, a week or a supply. The intake then greets a visitor with a banner saying a $250 discount is applied and will save them on their first month. A figure discounted for one month and undefined after it is not a monthly price, so the row carries none.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- LegitScript
- Claimed by provider
- Updated
- September 2026
What it is
A West Palm Beach telehealth marketer that connects patients with licensed providers for compounded semaglutide and tirzepatide, shipped to the home where permitted. It states that it is LegitScript certified and links the certification lookup.
How it works
A short online intake, review by a licensed provider, then fulfillment by a licensed pharmacy if a prescription is written. Three physicians are named on the site. The intake runs on a third-party telehealth funnel and collects name, email, phone and shipping state before any price is shown.
Pricing transparency
Semaglutide-based care starts at $99 and tirzepatide-based care at $149. The FAQ repeats both and adds that final pricing may vary depending on the treatment path selected through clinical review. No billing period appears beside either figure anywhere on the site. The banner running across the intake describes a $250 discount applied to a first month, which makes the published numbers an opening payment rather than a standing rate. A header promotion frames the same $99 as premium access with free shipping.
Branded vs compounded
Compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. AbundRX states this directly under its product cards and repeats it in the FAQ. The pharmacy that prepares the medication is not named.
Pros and watch-outs
What we like
- The compounding disclaimer sits directly under the prices
- LegitScript certification is claimed and linked for checking
- Three prescribing physicians are named on the site
- A toll-free number and street address are published
Watch-outs
- Neither published figure names a billing period
- The intake describes the price as a discounted first month
- Copy leans on may throughout and commits to very little
- Reaching a real price means handing over contact details
Best for
Buyers willing to finish an intake before seeing a rate.
Who should look elsewhere
Anyone costing out a year of treatment before signing up.
How AbundRX compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Bodybuilding Health+
A headline that is the monthly rate
See Bodybuilding Health+ → - Synergy Rx
Compounded and branded together
See Synergy Rx →
More GLP-1 sellers by price reviews: Breeze MedsCare Bare RxCollectiveCoreAge RxDirect MedsEden
Editor · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of AbundRX’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Is AbundRX $99 a month?
- The site never says. Both the product card and the FAQ read starting at $99 with no period attached, and the intake banner describes a $250 discount applied to a first month. What the second month costs is published nowhere.
- What does tirzepatide cost?
- Tirzepatide-based care is listed at $149 on the same basis as the $99 semaglutide figure, again with no supply period. The FAQ adds that final pricing may vary depending on the treatment path chosen after clinical review. The ongoing rate stays open.
- Which states does AbundRX serve?
- No state list is published. The intake asks which state medication will ship to and offers a dropdown covering the states, the District of Columbia and several territories. Whether a given state is actually served is settled inside that intake rather than before it.
- Are the medications FDA-approved?
- No. AbundRX states under its product cards that compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Its FAQ repeats the point. A prescription is still required, and treatment is not appropriate for everyone.